TY  - GEN
AU  - Chioato,A
AU  - Noseda,E
AU  - Stevens,M
AU  - Gaitatzis,N
AU  - Kleinschmidt,A
AU  - Picaud,H
TI  - Treatment with the interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label, parallel-group, randomized single-center study
SN  - 1556-679X
PY  - 2013///0405
KW  - Adolescent
KW  - Adult
KW  - Antibodies, Bacterial
KW  - blood
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antibodies, Viral
KW  - Female
KW  - Humans
KW  - Influenza Vaccines
KW  - immunology
KW  - Influenza, Human
KW  - Interleukin-17
KW  - antagonists & inhibitors
KW  - Male
KW  - Meningococcal Infections
KW  - Meningococcal Vaccines
KW  - Middle Aged
KW  - Neisseria meningitidis
KW  - Orthomyxoviridae
KW  - Th17 Cells
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1128/CVI.00386-12
ER  -